GLP-1 Weight Loss Drugs Linked to No Added Pregnancy Risk
A new review found no spike in complications for women using weight loss jabs around the time of conception.
Updated on Sept. 29, 2026 in Pregnancy
Live Poll
Do you trust the safety of weight loss medications if taken shortly before becoming pregnant?
A systematic review of two million pregnancies found that GLP-1 agonist weight loss medications did not increase risks of miscarriage, birth defects, or other complications. The study examined 8,325 women who used the injections within six months of a positive pregnancy test.
Why it matters
Current official guidelines advise against using these medications during pregnancy and two months prior to conception due to a lack of safety data. This study helps fill a critical gap in understanding how these common weight management tools affect early fetal development.
The study analyzed 8,325 pregnancies involving medication use near conception out of a total population of two million pregnancies. While the data shows no increased risk of issues like gestational diabetes or stillbirth, the long-term effects of higher dosages remain under investigation.
The players
Cell Press
A publisher of scientific journals that provides peer-reviewed research across the life and physical sciences.
The details
Researchers performed a systematic review of ten existing observational studies to compare health outcomes between pregnancies with and without GLP-1 exposure. By tracking data from 8,325 women who used these jabs in the months preceding pregnancy, the team looked for markers like abnormal birth weight and premature birth. The findings indicate that, contrary to past concerns, these medications do not appear to increase the frequency of major pregnancy complications.
Timeline
September 29, 2026: The study was published in the journal Cell Press.
The Home Front
This research contributes to the growing body of safety data for a class of drugs that have become household staples for weight management. It marks a significant update to the preliminary guidance that has long shaped the reproductive health planning of many families.
Women planning a pregnancy should continue to follow current official guidelines to stop using these injections two months prior to conception. Consult with your healthcare provider if you have concerns about your current medication regimen or future family planning.
The takeaway
While this study offers reassuring data regarding exposure near the time of conception, safety data for full-term use is still lacking. Continue to prioritize existing official advice to pause medication use before trying to conceive until further research is confirmed.
Further reading
For more on managing health decisions during your family journey, visit our Pregnancy section.
Source note: This article includes information reported by Mail Online.
Live Poll
Do you trust the safety of weight loss medications if taken shortly before becoming pregnant?
